SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior.

Molecular Genetics and Metabolism
Alona ShaldubinaG T Berry

Abstract

Two leading hypotheses to explain lithium action in bipolar disorder propose either inositol depletion or inhibition of GSK-3 as mechanisms of action. Behavioral effects of lithium are mimicked in Gsk-3beta+/- mice, but the contribution of inositol depletion to these behaviors has not been tested. According to the inositol depletion hypothesis, lithium-sensitive behavior is secondary to impaired phosphatidylinositol synthesis caused by inositol deficiency. By disrupting the sodium myo-inositol transporter1 gene, SMIT1, we show that depletion of brain myo-inositol in SMIT1+/- mice has no effect on lithium-sensitive behavior. These findings, taken together with our previous work showing that SMIT-/- mice have an even greater depletion of inositol in brain with no reduction in phosphatidylinositol levels, are difficult to reconcile with the current formulation of the inositol depletion hypothesis.

References

Oct 27, 1971·Nature: New Biology·J H Allison, M A Stewart
Dec 1, 1994·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Y BersudskyR H Belmaker
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·J M Baraban
Feb 9, 1994·Biochemical Pharmacology·R S Jope, M B Williams
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P S Klein, D A Melton
May 1, 1997·Developmental Biology·C M HedgepethP S Klein
Jul 14, 1997·FEBS Letters·J R Muñoz-MontañoJ Diaz-Nido
Jan 8, 1999·Cell Biology International·G SconzoG Giudice
Jun 1, 2001·Advances in Enzyme Regulation·J D YorkL E Stolz
May 17, 2002·Nature·Robin S B WilliamsAdrian J Harwood
Nov 7, 2002·Molecular Reproduction and Development·Xia WangGary D Smith
Nov 21, 2002·Pharmacology & Therapeutics·Nadia Gurvich, Peter S Klein
Feb 13, 2003·The Journal of Biological Chemistry·Gerard T BerryJohn J Greer
Oct 22, 2003·The Biochemical Journal·Stephen B Shears
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jean-Martin BeaulieuMarc G Caron
Apr 28, 2004·Molecular Genetics and Metabolism·Gerard T BerryEric Eccleston
Jul 30, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·W Timothy O'BrienPeter S Klein
Aug 19, 2004·The International Journal of Neuropsychopharmacology·Todd D GouldHusseini K Manji
Sep 20, 2005·The Journal of Pharmacology and Experimental Therapeutics·Oksana Kaidanovich-Beilin, Hagit Eldar-Finkelman

❮ Previous
Next ❯

Citations

Apr 27, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kim CrynsDieder Moechars
Oct 4, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert J SchloesserHusseini K Manji
Jan 20, 2011·Journal of Inherited Metabolic Disease·Gerard T Berry
Oct 29, 2010·Human Genomics and Proteomics : HGP·Alessio SquassinaMaria Del Zompo
May 29, 2007·Neuroscience and Biobehavioral Reviews·Kelley C O'Donnell, Todd D Gould
May 3, 2008·Bipolar Disorders·Yuly BersudskyRobert H Belmaker
Feb 19, 2014·Pharmacology, Biochemistry, and Behavior·Adem CanTodd D Gould
Mar 15, 2011·Physiology & Behavior·Melissa-Ann L ScottiStephen C Gammie
May 6, 2014·Frontiers in Physiology·Stephen A KempsonNiels C Danbolt
Sep 11, 2008·Psychopharmacology·Eleftheria TsaltasGeorge N Papadimitriou
Sep 17, 2009·Biochemical Society Transactions·Galila AgamR H Belmaker
Sep 17, 2009·Biochemical Society Transactions·Elena Di DanielPeter R Maycox
Sep 17, 2009·Biochemical Society Transactions·W Timothy O'Brien, Peter S Klein
May 1, 2016·Future Neurology·Wenxi Yu, Miriam L Greenberg
Feb 3, 2021·Cells·Melinda E SnitowPeter S Klein
May 8, 2009·Journal of Proteome Research·Insong James LeeMichael Shapiro
Nov 27, 2019·Molecular Neuropsychiatry·Gislaine Zilli RéusJoão Quevedo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
W Timothy O'BrienP S Klein
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Kim CrynsThomas Steckler
© 2022 Meta ULC. All rights reserved